Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
EditorialEditorial

Thallium-201 and Technetium-99m-Sestamibi for Assessing Viable Myocardium

Robert O. Bonow and Vasken Dilsizian
Journal of Nuclear Medicine May 1992, 33 (5) 815-818;
Robert O. Bonow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vasken Dilsizian
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 33 no. 5 815-818
PubMed 
1533248

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X

Copyright & Usage 
COPYRIGHT © 1992 by The Society of Nuclear Medicine, Inc.

Author Information

Statistics from Altmetric.com

Cited By...

  • 47 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: January 2007 to April 2025

AbstractFullPdf
Jan 2007005
Feb 2007003
Mar 2007002
Apr 2007001
May 2007002
Jul 2007005
Sep 2007006
Oct 2007006
Nov 2007003
Dec 2007002
Jan 2008001
Feb 2008003
Mar 20080012
Apr 2008001
May 2008002
Jun 2008003
Jul 2008004
Aug 2008003
Sep 2008006
Oct 2008004
Nov 2008003
Dec 2008002
Feb 2009005
Mar 2009002
Apr 2009001
May 2009006
Jun 2009001
Jul 2009002
Aug 2009002
Sep 2009003
Nov 2009002
Dec 2009001
Feb 2010006
Mar 2010006
Apr 2010001
May 2010001
Jun 2010007
Jul 2010003
Aug 2010001
Sep 2010001
Oct 2010004
Nov 2010001
Dec 2010002
Jan 2011005
Feb 2011002
Mar 2011002
Apr 2011003
May 2011001
Jul 2011004
Aug 2011008
Sep 2011004
Oct 2011007
Nov 2011005
Dec 2011003
Jan 2012005
Feb 2012005
Mar 2012003
Apr 2012003
May 2012006
Jun 2012004
Jul 2012004
Aug 2012001
Sep 2012002
Oct 2012001
Nov 2012002
Jan 2013001
Feb 2013004
Mar 2013003
Apr 2013004
May 2013008
Jun 2013004
Sep 2013002
Dec 2013003
Feb 2014005
Mar 2014002
Apr 2014004
May 2014001
Jun 2014002
Jul 2014001
Aug 2014003
Sep 2014001
Oct 2014001
Nov 20140012
Dec 2014002
Feb 2015003
Mar 2015001
Apr 2015002
May 2015003
Jun 2015003
Jul 2015007
Sep 2015001
Oct 2015001
Nov 2015001
Dec 2015001
Jan 2016004
Feb 2016009
Mar 2016007
Apr 2016009
May 2016005
Jun 2016001
Jul 20160010
Aug 2016006
Sep 2016007
Oct 2016008
Nov 2016017
Dec 2016001
Jan 2017005
Feb 2017001
Jun 2017001
Nov 2017005
Feb 2018003
Mar 2018002
Apr 2018003
Jun 2018001
Jul 2018004
Aug 2018003
Sep 2018002
Oct 2018001
Dec 2018002
Jan 2019001
Feb 2019001
Mar 2019001
Apr 2019001
Aug 2019001
Sep 20190019
Oct 2019002
Nov 2019003
Dec 2019001
Feb 2020001
Mar 2020001
Apr 2020001
Aug 2020004
Nov 2020001
Dec 2020001
Feb 2021003
May 2021001
Jun 2021001
Jul 2021005
Aug 2021001
Sep 2021002
Oct 2021005
Nov 2021003
Dec 2021006
Jan 2022008
Feb 2022002
Apr 2022001
May 2022001
Jun 2022001
Jul 2022001
Aug 2022001
Sep 2022001
Oct 2022001
Dec 2022006
Jan 2023002
Mar 2023004
Apr 2023001
Jul 2023006
Aug 2023002
Nov 2023003
Dec 2023001
Apr 2024004
May 20240014
Jun 2024001
Jul 2024009
Aug 2024005
Oct 2024006
Jan 2025002
Feb 2025002
Mar 2025003
Apr 2025009
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 33, Issue 5
May 1, 1992
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Thallium-201 and Technetium-99m-Sestamibi for Assessing Viable Myocardium
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Thallium-201 and Technetium-99m-Sestamibi for Assessing Viable Myocardium
Robert O. Bonow, Vasken Dilsizian
Journal of Nuclear Medicine May 1992, 33 (5) 815-818;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Thallium-201 and Technetium-99m-Sestamibi for Assessing Viable Myocardium
Robert O. Bonow, Vasken Dilsizian
Journal of Nuclear Medicine May 1992, 33 (5) 815-818;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Radionuclide techniques for the assessment of myocardial viability and hibernation
  • Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction
  • Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography
  • Prediction of Improvement of Regional Left Ventricular Function After Surgical Revascularization : A Comparison of Low-Dose Dobutamine Echocardiography With 201Tl Single-Photon Emission Computed Tomography
  • Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects
  • Google Scholar

More in this TOC Section

  • The Australian National Total-Body PET Facility—A Shared Resource and Risk Model for Implementing Total-Body PET
  • Funding Reductions Threaten the Future of Medical Innovation
  • A Brief Report on the Results of the 2024 National Survey of Nuclear Medicine Conducted by the Chinese Society of Nuclear Medicine
Show more Editorial

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire